Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis Pharma, and LENZ Therapeutics, after getting FDA approval for its ...

Please provide your email address to receive an email when new articles are posted on . In a study, the most common complaint after presbyopia-correcting IOL implantation was blurry vision. IOL ...

When it comes to refractive surgery, not all patients are created equal. A 28-year-old patient with myopia desiring to be free of glasses is different from a 52-year-old patient w ...

Today, millions of people live with myopia, presbyopia, cataracts, and dry eye symptoms that affect their quality of life every day. For people with myopia, summer activities can become frustrating.

If you are finding yourself holding restaurant menus at arm’s length or squinting at your phone, you are likely experiencing presbyopia. This natural, age-related condition affects nearly everyone ...

WASHINGTON — Phentolamine ophthalmic solution improved near vision in adults with presbyopia, with over 20 hours of improvement from a single administration, the VEGA-3 trial showed. With the drops, ...

Credit: Tenpoint Therapeutics. Tenpoint Therapeutics launches Yuvezzi, a fixed-dose combination ophthalmic solution for presbyopia. Yuvezzi is supplied in single dose vials containing carbachol 27.5mg ...

The most common side effects were headache, impaired vision, and temporary eye pain or eye irritation. "The FDA approval of Yuvezzi represents a significant milestone for the millions of people in the ...

The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...

Yuvezzi is the first FDA-approved dual-agent eye drop for presbyopia, combining carbachol and brimonidine tartrate. Phase III trials showed Yuvezzi significantly improved near visual acuity without ...

Presbyopia is a progressive, age-related loss of the eye’s ability to focus on objects in the near distance. The most common symptom of presbyopia is blurry vision, but it may also cause eye strain ...

(RTTNews) - LENZ Therapeutics, Inc. (LENZ), a pharmaceutical company that recently secured FDA approval for its aceclidine ophthalmic solution VIZZ for presbyopia, has reported preliminary Q4 ...